EUVIMEDEUVIMED entdecken
Crossref

Plasma Proteomics Across Three Generations of Mass Spectrometry Instruments: Lessons for Biofluid Method Optimisation

Jack Edwards, Dylan H Multari, Toby Dite, Steve Binos, Clare Shugg, Andrew I Webb, Laura F Dagley, Samantha J Emery-Corbin

PROTEOMICS · 2026-07 · 26 (7) · 131-145

DOI: 10.1002/pmic.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 15.04.2026. Verfasst von Jack Edwards und 7 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Technology and Biology Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Proteomics, Blood Proteins, Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In biomarker discovery phases clinical proteomics provides large‐scale identification and quantification of proteins in donor samples. For these studies plasma is the most frequently used biofluid, as it reflects both physiological and pathological states of the circulating proteome. However, the vast dynamic range of proteins in plasma remains a significant challenge, where low‐abundance biomarkers are suppressed by high‐abundance proteins, despite substantial technological improvements. Often the focus of improving outcomes in plasma proteomic workflows are within the biofluid's sample preparation, although adjusting MS methods dramatically improves detection and sampling of lower abundance proteins. Herein we have benchmarked various liquid chromatography (LC) and data‐independent acquisition (DIA) methods across three generations of mass spectrometry instruments: timsTOF Pro (2017), Orbitrap Eclipse (2020), and Orbitrap Astral (2023). This study explored 27 combinations of LC‐MS methods across 200 hours of instrument acquisition time, encompassing varying LC and MS settings. While each instrument generation significantly improved performance, each instrument also revealed a unique and different tuneable range to improve performance in plasma samples, highlighting the benefit of investing in plasma‐specific method development for any mass spectrometer. We also evaluated the detection and quantification capabilities of each instrument via a unique approach of mixing paired platelet poor plasma (PPP) and platelet rich plasma (PRP), introducing linear contamination markers for quantitative assessment. This approach tested each instrument's sensitivity to detect low‐abundance peptides and evaluated their quantitative accuracy. Lastly, we performed testing of the Orbitrap Astral's parallel ion processing capabilities with the aim of improving low‐abundance protein identifications using gas‐phase enrichment (GPE). More specifically, we show that optimisation of MS2 AGC targets and injection time enhanced GPE of low‐abundance peptides, improving detection in plasma samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsBlood ProteinsMass SpectrometryLiquid Chromatography-Mass SpectrometryProteomeHumansBiomarkersChromatography, Liquid

Stichwörter der Autor:innen

astralautomatic gain controlclinical proteomicsdata‐independent acquisitionorbitrapplasma proteomicsquantitation

Substanzen

Blood ProteinsBiomarkersProteome

Autor:innen und Institutionen

  • Advanced Technology and Biology Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
  • Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • CSL Seqirus, Parkville, VIC, Australia.
  • Monash Proteomics & Metabolomics Platform, Department of Biochemistry and Molecular Biology, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institutew, Monash University, Clayton, Victoria, Aust…
  • CSL, Parkville, VIC, Australia.
  • Department of Diagnostic Haematology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Zitieren

APA

Edwards, J., Multari, D. H., Dite, T., Binos, S., Shugg, C., Webb, A. I., Dagley, L. F., & Emery-Corbin, S. J. (2026). Plasma Proteomics Across Three Generations of Mass Spectrometry Instruments: Lessons for Biofluid Method Optimisation. PROTEOMICS, 26(7), 131-145. https://doi.org/10.1002/pmic.70127

Vancouver

Edwards J, Multari DH, Dite T, Binos S, Shugg C, Webb AI, et al. Plasma Proteomics Across Three Generations of Mass Spectrometry Instruments: Lessons for Biofluid Method Optimisation. PROTEOMICS. 2026;26(7):131-145. doi:10.1002/pmic.70127

BibTeX
@article{Edwards2026,
  author = {Edwards, Jack and Multari, Dylan H and Dite, Toby and Binos, Steve and Shugg, Clare and Webb, Andrew I and Dagley, Laura F and Emery-Corbin, Samantha J},
  title = {Plasma Proteomics Across Three Generations of Mass Spectrometry Instruments: Lessons for Biofluid Method Optimisation},
  journal = {PROTEOMICS},
  year = {2026},
  volume = {26},
  number = {7},
  pages = {131--145},
  doi = {10.1002/pmic.70127}
}
Kostenlos starten →